Ƶ
birminghampost
Load mobile navigation
Around The Ƶ
West Midlands
East Midlands
South West
North West
North East
Yorkshire & Humber
South East
East
London
Northern Ireland
Wales
Expand
Sectors
Enterprise
Professional Services
Retail & Consumer
Economic Development
Tech
Commercial Property
Manufacturing
Ports & Logistics
Law
Finance
Expand
Climate
Opinion
Ƶ
SUBSCRIBE
PREMIUM
Follow us
Send me daily emails
Advertise With Us
Contact Us
About Us
Newsletter Signup
Contact Us
About Us
Advertise with Us
Competition Rules
How to Complain
Corrections and Clarifications
Terms and Conditions
Privacy Notice
AI Notice
Cookie Notice
Newsletter Signup
RSS feeds
© 2026 a Ƶ
Pharmaceuticals
12:43, 11 MAR 2025
Aptamer Group doubles half-year revenue as firm sees 'strong and sustainable' commercial momentum
Company Results
The Yorl business said it is now signing multiple new contracts with global market-leading pharmaceutical companies
Bookmark
Northumberland life sciences firm seals £500k investment to fund trials for cancer-prevention treatment
Deals
The Alnwick business is poised to draw up a clinical trial for HELIX, the firm's first product being brought to market
Bookmark
Hikma Pharmaceuticals' revenue grows nine per cent to £2.47bn as profit booms
By City AM
The pharmaceutical company said the bulk of its growth came from its North American arm as well as recent product launches
Bookmark
North East life sciences experiencing a wave of optimism - but there are challenges to overcome
Chamber of Commerce
The first of what is hoped to be an annual study of the region's sector is positive but lack of funding, laboratory space and big changes with the US trading relationship pose difficulties for firms
Bookmark
Astrazeneca says it's 'too big' to base CEO's pay packet on FTSE 100 peers
By City AM
Astrazeneca has defended the £14.7 million pay package handed to chief executive Pascal Soriot, saying the group is too big and complex to base his remuneration on the rest of the FTSE 100 index
Bookmark
Healthtech start-up bags Europe's largest pre-seed funding round for female founders
By City AM
Level Zero Health raised the funds to accelerate the development of the world's first remote and continuous hormone monitoring device, powered by first of a kind DNA-based sensors
Bookmark
Historic building in Newcastle signs up three tenants after £1.5m transformation
property news
The former Cafe Royale building will soon welcome Mowgli Street Food alongside two other tenants in upper floor offices
Bookmark
Astrazeneca's revenue soars despite China woes as it 'doesn't pay £700k tax bill'
By City AM
The pharmaceutical giant's revenue jumped 21 per cent last year despite growing troubles over its presence in China, where it is alleged to have not paid a $900,000 importation tax bill
Bookmark
Gateshead drug firm Shield Therapeutics to see revenues rise 84% amid boost in prescriptions
Pharmaceuticals
The firm - which specialises in iron deficiency tablet Accrufer - has announced a “significant step-up in revenue” during 2024
Bookmark
GSK boosts 2031 revenue target to over £40bn following robust Q4 results
By City AM
The pharma giant hiked its 2031 sales forecast to more than £40bn, up from £38bn, after reporting better than forecast fourth quarter earnings.
Bookmark
AstraZeneca halts vaccine plant expansion citing insufficient government support
Pharmaceuticals
The pharmaceutical giant said it was no longer pursuing a £450 million investment in a vaccine manufacturing plant in Merseyside after discussions with the Government
Bookmark
The Newcastle firm making waves in biotech inspired by a four-toed African pygmy hedgehog
Deals
Atelerix - which also takes its name from the hedgehog - has secured more than £1m in funding this year alone
Bookmark
Ƶ government delays 'could threaten' AstraZeneca's new £450m vaccine facility in Liverpool
Pharmaceuticals
Last year it was reported that AstraZeneca was considering moving the manufacturing of its Covid-19 jab overseas amid a 'deadlock' in its talks with the Ƶ government
Bookmark
Tyneside pharma firm Shield Therapeutics appoints new US-based CEO
Appointments
The company said Mr Lundstrom’s interim leadership has been instrumental in driving the firm’s growth
Bookmark
Pharma consultancy Coronado Research creates jobs with Newcastle office launch
Pharmaceuticals
The newly established firm specialises in building models for drug development that can help patients of rare conditions
Bookmark
Life sciences sector key to driving Welsh economy says Jo Stevens
Wales
The Welsh Secretary has held talks with key figures from the sector in Wales that employs more than 12,000
Bookmark
Welsh firms underperforming on research and development spending
Enterprise
While Welsh firms make up around a 5% of the Ƶ population there share of R&D spending is just 1.7%
Bookmark
Alliance Pharma accepts £350m takeover bid from DBAY Advisors
By City AM
The AIM-listed firm has had its board recommend the takeover unanimously by asset manager DBAY Advisors
Bookmark
Morson Group grows specialist engineering arm with deal for Orange Solutions
North West
'As part of the Morson Group, we will continue to build on our reputation'
Bookmark
Cramlington's Merit recruits 18 new apprentices to train up next generation
Employment
As well as getting training and experience the recruits are also guaranteed job security after completing the apprenticeship
Bookmark
Dairy company that sells to Waitrose and Sainsbury's to create jobs after securing £750k
Deals
The Somerset creamery has relocated to a bigger facility and is planning to boost production
Bookmark
Northumberland's Sterling Pharma Solutions sees signs of market recovery after challenging year
Company Results
The company is overcoming post-Covid challenges and has continued to invest and take on more staff in the last year
Bookmark
North East deals of the week: key contracts, investments and acquisitions
Deals
This week's round-up includes Hitachi Rail, BSF Enterprise, Sore Paws, AMLo Biosciences, MTL Projects and Mark Thompson Lifesciences and Newcells Biotech
Bookmark
Tyneside pharma firm Shield Therapeutics seeks to raise $10m through subscription by largest investor
Deals
The Newcastle company has signed an agreement with AOP Health International Management AG
Bookmark
1
2
3
4
5
Story Saved
You can find this story in
My Bookmarks.
Or by navigating to the user icon in the top right.